RU92004569A - PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION - Google Patents

PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION

Info

Publication number
RU92004569A
RU92004569A RU92004569/14A RU92004569A RU92004569A RU 92004569 A RU92004569 A RU 92004569A RU 92004569/14 A RU92004569/14 A RU 92004569/14A RU 92004569 A RU92004569 A RU 92004569A RU 92004569 A RU92004569 A RU 92004569A
Authority
RU
Russia
Prior art keywords
stress
protective
active substance
pharmaceutical product
pharmaceutical preparation
Prior art date
Application number
RU92004569/14A
Other languages
Russian (ru)
Other versions
RU2025124C1 (en
Inventor
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Т.Т. Кондрашова
Н.М. Бурбенская
Original Assignee
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Т.Т. Кондрашова
Н.М. Бурбенская
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by И.А. Комиссарова, Ю.В. Гудкова, Т.Д. Солдатенкова, Т.Т. Кондрашова, Н.М. Бурбенская filed Critical И.А. Комиссарова
Application granted granted Critical
Publication of RU2025124C1 publication Critical patent/RU2025124C1/en
Publication of RU92004569A publication Critical patent/RU92004569A/en

Links

Claims (5)

1. Фармацевтический препарат антистрессорного, стресспротекторного и ноотропного действия для сублингвального применения, включающий действующее вещество и фармацевтический носитель, характеризующийся тем, что в качестве действующего вещества он содержит аминокислоту глицин или ее фармацевтически приемлемую соль.1. A pharmaceutical preparation of antistress, stress-protective and nootropic action for sublingual administration, comprising an active substance and a pharmaceutical carrier, characterized in that it contains an amino acid glycine or a pharmaceutically acceptable salt thereof as an active substance. 2. Препарат по п.1 в виде таблеток, характеризующийся тем, что он содержит действующее вещество в количестве 0,1 - 0,2 г на одну таблетку. 2. The drug according to claim 1 in the form of tablets, characterized in that it contains the active substance in an amount of 0.1 - 0.2 g per tablet. 3. Препарат по пп.1 и 2, характеризующийся тем, что в качестве фармацевтического носителя он содержит метилцеллюлозу в количестве 0,5 - 2 мас.%. 3. The drug according to claims 1 and 2, characterized in that as a pharmaceutical carrier it contains methyl cellulose in an amount of 0.5 to 2 wt.%. 4. Способ профилактики и лечения стрессовых состояний путем сублингвального введения эффективного количества фармацевтического препарата по п. 1. 4. A method for the prevention and treatment of stressful conditions by sublingual administration of an effective amount of a pharmaceutical preparation according to claim 1. 5. Способ повышения умственной работоспособности путем сублингвального введения эффективного количества фармацевтического препарата по п.1. 5. A method of increasing mental performance by sublingually administering an effective amount of a pharmaceutical preparation according to claim 1.
RU9292004569A 1992-01-10 1992-12-11 Antistress, stress-protective, nootropic agent, method of prophylaxis and treatment of stress states and a method of mental workin capacity increase RU2025124C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU9200005 1992-01-10
RUSU92/00005 1992-01-10

Publications (2)

Publication Number Publication Date
RU2025124C1 RU2025124C1 (en) 1994-12-30
RU92004569A true RU92004569A (en) 1998-05-10

Family

ID=21617814

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9292004569A RU2025124C1 (en) 1992-01-10 1992-12-11 Antistress, stress-protective, nootropic agent, method of prophylaxis and treatment of stress states and a method of mental workin capacity increase

Country Status (2)

Country Link
CN (1) CN1074134A (en)
RU (1) RU2025124C1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007615B1 (en) * 2005-12-16 2006-12-29 Некоммерческое Учреждение "Научно-Исследовательский Институт Цитохимии И Молекулярной Фармакологии" A mixture of medicament quality control “0.1 g sublingual glycine tablets” and method for preparing thereof
RU2304444C1 (en) * 2006-05-23 2007-08-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Peptide possessing stress-protecting effect, pharmaceutical composition based on thereof and method for its using
RU2322240C1 (en) * 2006-07-05 2008-04-20 Лев Давидович Раснецов Medicinal agent possessing nootropic activity (variants)
RU2452480C2 (en) * 2010-09-13 2012-06-10 Федеральное государственное бюджетное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) Pharmaceutical composition of glycin and method for preparing it
RU2505294C1 (en) * 2012-06-15 2014-01-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации N-(4-acetoxybenzoyl)glycine lithium salt possessing tranquilising and nootropic action
RU2546300C1 (en) * 2013-12-24 2015-04-10 Градстейн Инвестментс Лимитед, Кипр Composition having action on central nervous system and using it
RU2576240C1 (en) * 2015-02-11 2016-02-27 Открытое Акционерное Общество "Татхимфармпрепараты" Pharmaceutical composition comprising combination of glycine and tetramethyltetraazabicyclooctandione (version)

Similar Documents

Publication Publication Date Title
AU2001264736B2 (en) Gabapentin analogues for sleep disorders
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
ATE424810T1 (en) A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER
RU94032150A (en) Medicinal agent exhibiting delayed release of active-acting substance
RU2000100361A (en) SODIUM SALT OMEGRAZOLE
RU93055870A (en) BIPHENYL DERIVATIVES, THE METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND HEART DISEASES
JPH0584286B2 (en)
ATE73656T1 (en) ANTI-INFLAMMATORY MEDICATION CONTAINING IBUPROFEN WHICH IN AQUEOUS SOLUTION HAS NO BITTER TASTE, LARYNX IRRITATION AND INTESTINAL TOXICITY.
RU95101385A (en) Products containing g-csf and tnf-binding protein
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
RU92004569A (en) PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION
DE3866045D1 (en) MEDICINES FOR TREATING URAEMIE.
JPH0745410B2 (en) Cardiac dysfunction treatment
RU94040869A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RANITIDINE SALTS AND BISMUTH CARBOXYLATES AND THE METHOD FOR PRODUCING THEM
RU2001126056A (en) The use of (R) -arylpropionic acids for the manufacture of medicaments for the treatment of diseases of humans and animals that can be treated with therapeutic effect by inhibiting the activation of NF-kB
RU99100703A (en) MODIFIED FORM OF HYDROCHLORIDE R (-) - N - (4,4-DI (3-METHYL-THIEN-2-IL) BUT-3-ENYL) -NIPECOTHIC ACID
RU98103506A (en) APPLICATION OF BASIC AMINO ACIDS AND DERIVATIVES TO REDUCE THE CONTENT OF CERAMIDES
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
RU95100307A (en) PHARMACEUTICAL PREPARATION OF ANTI-ALCOHOL AND NOOTROPIC ACTION
RU2002109234A (en) A method for treating metabolic disorders, especially diabetes or diseases or conditions associated with diabetes
SU533323A3 (en) Method for enhancing biological activity of α-oxitriptophan
HU226374B1 (en) Pharmaceutical combination of a bradykinin antagonist and an antiviral agent
IE893502L (en) Formulations
RU2003132049A (en) PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity
JPS6442430A (en) Side effect remover for chemotherapeutic agent